Timing of anticoagulation after recent ischaemic stroke in patients with atrial fibrillation
Year: 2018
Type: review
Source: The Lancet Neurology
Institutions: University of Basel, University Hospital of Basel, National Hospital for Neurology and Neurosurgery, UCL Queen Square Institute of Neurology, University College London, University of Perugia, University of Glasgow, The University of Texas at Austin, Felix Platter-Hospital, University of Bern, University Hospital of Bern, Lund University, Skåne University Hospital
Language: English
Subfield: Cardiology and Cardiovascular Medicine
Field: Medicine
Domain: Health Sciences
Keywords: atrial fibrillation, ischemic stroke, oral anticoagulation, direct oral anticoagulants, timing of anticoagulation initiation, intracranial hemorrhage, hemorrhagic transformation, recurrent ischemic stroke, secondary stroke prevention, vitamin K antagonists, apixaban, dabigatran, edoxaban, rivaroxaban
Open Access status: green
Funders: NIHR Biomedical Research Centre, Royal Marsden NHS Foundation Trust/Institute of Cancer Research, National Institute for Health and Care Research, British Heart Foundation, Stroke Association, Rosetrees Trust, Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung, European Stroke Organisation, National Institutes of Health, National Heart, Lung, and Blood Institute
OpenAlex ID: W2899533998
